 | • レポートコード：GIR-107A14683 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、一次抗体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。一次抗体の種類別市場規模（モノクローナル抗体、ポリクローナル抗体）、用途別市場規模（病院、生命科学、研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・一次抗体の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bio-Rad、Biorbyt、Abcam、Thermo Fisher Scientific、Creative Diagnostics、Novus Biologicals、SouthernBiotech、Boster Bio、OriGene、Genscript Biotech、Proteintech、Roche Diagnostics、HyTest ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体、ポリクローナル抗体 ・用途別分析2016年-2026年：病院、生命科学、研究所 ・一次抗体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・一次抗体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・一次抗体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・一次抗体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・一次抗体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Primary Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Primary Antibody size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Primary Antibody market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Primary Antibody market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Polyclonal Antibody
Market segment by Application can be divided into
Hospital
Life Sciences
Laboratory
The key market players for global Primary Antibody market are listed below:
Bio-Rad
Biorbyt
Abcam
Thermo Fisher Scientific
Creative Diagnostics
Novus Biologicals
SouthernBiotech
Boster Bio
OriGene
Genscript Biotech
Proteintech
Roche Diagnostics
HyTest
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Primary Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Primary Antibody, with price, sales, revenue and global market share of Primary Antibody from 2019 to 2021.
Chapter 3, the Primary Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primary Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Primary Antibody market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Primary Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Primary Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Primary Antibody Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibody
1.3 Market Analysis by Application
1.3.1 Overview: Global Primary Antibody Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Life Sciences
1.3.4 Laboratory
1.4 Global Primary Antibody Market Size & Forecast
1.4.1 Global Primary Antibody Sales in Value (2016-2026))
1.4.2 Global Primary Antibody Sales in Volume (2016-2026)
1.4.3 Global Primary Antibody Price by Type (2016-2026) & (USD/mg)
1.5 Global Primary Antibody Production Capacity Analysis
1.5.1 Global Primary Antibody Total Production Capacity (2016-2026)
1.5.2 Global Primary Antibody Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Primary Antibody Market Drivers
1.6.2 Primary Antibody Market Restraints
1.6.3 Primary Antibody Trends Analysis
2 Manufacturers Profiles
2.1 Bio-Rad
2.1.1 Bio-Rad Details
2.1.2 Bio-Rad Major Business
2.1.3 Bio-Rad Primary Antibody Product and Services
2.1.4 Bio-Rad Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Biorbyt
2.2.1 Biorbyt Details
2.2.2 Biorbyt Major Business
2.2.3 Biorbyt Primary Antibody Product and Services
2.2.4 Biorbyt Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Abcam
2.3.1 Abcam Details
2.3.2 Abcam Major Business
2.3.3 Abcam Primary Antibody Product and Services
2.3.4 Abcam Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Primary Antibody Product and Services
2.4.4 Thermo Fisher Scientific Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Creative Diagnostics
2.5.1 Creative Diagnostics Details
2.5.2 Creative Diagnostics Major Business
2.5.3 Creative Diagnostics Primary Antibody Product and Services
2.5.4 Creative Diagnostics Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Novus Biologicals
2.6.1 Novus Biologicals Details
2.6.2 Novus Biologicals Major Business
2.6.3 Novus Biologicals Primary Antibody Product and Services
2.6.4 Novus Biologicals Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 SouthernBiotech
2.7.1 SouthernBiotech Details
2.7.2 SouthernBiotech Major Business
2.7.3 SouthernBiotech Primary Antibody Product and Services
2.7.4 SouthernBiotech Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Boster Bio
2.8.1 Boster Bio Details
2.8.2 Boster Bio Major Business
2.8.3 Boster Bio Primary Antibody Product and Services
2.8.4 Boster Bio Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 OriGene
2.9.1 OriGene Details
2.9.2 OriGene Major Business
2.9.3 OriGene Primary Antibody Product and Services
2.9.4 OriGene Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Genscript Biotech
2.10.1 Genscript Biotech Details
2.10.2 Genscript Biotech Major Business
2.10.3 Genscript Biotech Primary Antibody Product and Services
2.10.4 Genscript Biotech Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Proteintech
2.11.1 Proteintech Details
2.11.2 Proteintech Major Business
2.11.3 Proteintech Primary Antibody Product and Services
2.11.4 Proteintech Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Roche Diagnostics
2.12.1 Roche Diagnostics Details
2.12.2 Roche Diagnostics Major Business
2.12.3 Roche Diagnostics Primary Antibody Product and Services
2.12.4 Roche Diagnostics Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 HyTest
2.13.1 HyTest Details
2.13.2 HyTest Major Business
2.13.3 HyTest Primary Antibody Product and Services
2.13.4 HyTest Primary Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Primary Antibody Sales by Manufacturer
3.1 Global Primary Antibody Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Primary Antibody Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Primary Antibody
3.4 Market Concentration Rate
3.4.1 Top 3 Primary Antibody Manufacturer Market Share
3.4.2 Top 6 Primary Antibody Manufacturer Market Share
3.5 Global Primary Antibody Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Primary Antibody Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Primary Antibody Market Size by Region
4.1.1 Global Primary Antibody Sales in Volume by Region (2016-2026)
4.1.2 Global Primary Antibody Revenue by Region (2016-2026)
4.2 North America Primary Antibody Revenue (2016-2026)
4.3 Europe Primary Antibody Revenue (2016-2026)
4.4 Asia-Pacific Primary Antibody Revenue (2016-2026)
4.5 South America Primary Antibody Revenue (2016-2026)
4.6 Middle East and Africa Primary Antibody Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Primary Antibody Sales in Volume by Type (2016-2026)
5.2 Global Primary Antibody Revenue by Type (2016-2026)
5.3 Global Primary Antibody Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Primary Antibody Sales in Volume by Application (2016-2026)
6.2 Global Primary Antibody Revenue by Application (2016-2026)
6.3 Global Primary Antibody Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Primary Antibody Sales by Type (2016-2026)
7.2 North America Primary Antibody Sales by Application (2016-2026)
7.3 North America Primary Antibody Market Size by Country
7.3.1 North America Primary Antibody Sales in Volume by Country (2016-2026)
7.3.2 North America Primary Antibody Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Primary Antibody Sales by Type (2016-2026)
8.2 Europe Primary Antibody Sales by Application (2016-2026)
8.3 Europe Primary Antibody Market Size by Country
8.3.1 Europe Primary Antibody Sales in Volume by Country (2016-2026)
8.3.2 Europe Primary Antibody Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Primary Antibody Sales by Type (2016-2026)
9.2 Asia-Pacific Primary Antibody Sales by Application (2016-2026)
9.3 Asia-Pacific Primary Antibody Market Size by Region
9.3.1 Asia-Pacific Primary Antibody Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Primary Antibody Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Primary Antibody Sales by Type (2016-2026)
10.2 South America Primary Antibody Sales by Application (2016-2026)
10.3 South America Primary Antibody Market Size by Country
10.3.1 South America Primary Antibody Sales in Volume by Country (2016-2026)
10.3.2 South America Primary Antibody Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Primary Antibody Sales by Type (2016-2026)
11.2 Middle East & Africa Primary Antibody Sales by Application (2016-2026)
11.3 Middle East & Africa Primary Antibody Market Size by Country
11.3.1 Middle East & Africa Primary Antibody Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Primary Antibody Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Primary Antibody Typical Distributors
12.3 Primary Antibody Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Primary Antibody Revenue by Type, (USD Million), 2021-2026
Table 2. Global Primary Antibody Revenue by Application, (USD Million), 2021-2026
Table 3. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 4. Bio-Rad Major Business
Table 5. Bio-Rad Primary Antibody Product and Services
Table 6. Bio-Rad Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 8. Biorbyt Major Business
Table 9. Biorbyt Primary Antibody Product and Services
Table 10. Biorbyt Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Abcam Basic Information, Manufacturing Base and Competitors
Table 12. Abcam Major Business
Table 13. Abcam Primary Antibody Product and Services
Table 14. Abcam Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Primary Antibody Product and Services
Table 18. Thermo Fisher Scientific Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 20. Creative Diagnostics Major Business
Table 21. Creative Diagnostics Primary Antibody Product and Services
Table 22. Creative Diagnostics Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 24. Novus Biologicals Major Business
Table 25. Novus Biologicals Primary Antibody Product and Services
Table 26. Novus Biologicals Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. SouthernBiotech Basic Information, Manufacturing Base and Competitors
Table 28. SouthernBiotech Major Business
Table 29. SouthernBiotech Primary Antibody Product and Services
Table 30. SouthernBiotech Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Boster Bio Basic Information, Manufacturing Base and Competitors
Table 32. Boster Bio Major Business
Table 33. Boster Bio Primary Antibody Product and Services
Table 34. Boster Bio Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. OriGene Basic Information, Manufacturing Base and Competitors
Table 36. OriGene Major Business
Table 37. OriGene Primary Antibody Product and Services
Table 38. OriGene Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Genscript Biotech Basic Information, Manufacturing Base and Competitors
Table 40. Genscript Biotech Major Business
Table 41. Genscript Biotech Primary Antibody Product and Services
Table 42. Genscript Biotech Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Proteintech Basic Information, Manufacturing Base and Competitors
Table 44. Proteintech Major Business
Table 45. Proteintech Primary Antibody Product and Services
Table 46. Proteintech Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 48. Roche Diagnostics Major Business
Table 49. Roche Diagnostics Primary Antibody Product and Services
Table 50. Roche Diagnostics Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. HyTest Basic Information, Manufacturing Base and Competitors
Table 52. HyTest Major Business
Table 53. HyTest Primary Antibody Product and Services
Table 54. HyTest Primary Antibody Sales (mg), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Primary Antibody Sales by Manufacturer (2019-2021e) & (mg)
Table 56. Global Primary Antibody Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Primary Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Primary Antibody Production Capacity by Company, (mg): 2020 VS 2021
Table 59. Head Office and Primary Antibody Production Site of Key Manufacturer
Table 60. Primary Antibody New Entrant and Capacity Expansion Plans
Table 61. Primary Antibody Mergers & Acquisitions in the Past Five Years
Table 62. Global Primary Antibody Sales by Region (2016-2021e) & (mg)
Table 63. Global Primary Antibody Sales by Region (2021-2026) & (mg)
Table 64. Global Primary Antibody Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Primary Antibody Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Primary Antibody Sales by Type (2016-2021e) & (mg)
Table 67. Global Primary Antibody Sales by Type (2021-2026) & (mg)
Table 68. Global Primary Antibody Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Primary Antibody Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Primary Antibody Price by Type (2016-2021e) & (USD/mg)
Table 71. Global Primary Antibody Price by Type (2021-2026) & (USD/mg)
Table 72. Global Primary Antibody Sales by Application (2016-2021e) & (mg)
Table 73. Global Primary Antibody Sales by Application (2021-2026) & (mg)
Table 74. Global Primary Antibody Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Primary Antibody Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Primary Antibody Price by Application (2016-2021e) & (USD/mg)
Table 77. Global Primary Antibody Price by Application (2021-2026) & (USD/mg)
Table 78. North America Primary Antibody Sales by Country (2016-2021e) & (mg)
Table 79. North America Primary Antibody Sales by Country (2021-2026) & (mg)
Table 80. North America Primary Antibody Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Primary Antibody Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Primary Antibody Sales by Type (2016-2021e) & (mg)
Table 83. North America Primary Antibody Sales by Type (2021-2026) & (mg)
Table 84. North America Primary Antibody Sales by Application (2016-2021e) & (mg)
Table 85. North America Primary Antibody Sales by Application (2021-2026) & (mg)
Table 86. Europe Primary Antibody Sales by Country (2016-2021e) & (mg)
Table 87. Europe Primary Antibody Sales by Country (2021-2026) & (mg)
Table 88. Europe Primary Antibody Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Primary Antibody Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Primary Antibody Sales by Type (2016-2021e) & (mg)
Table 91. Europe Primary Antibody Sales by Type (2021-2026) & (mg)
Table 92. Europe Primary Antibody Sales by Application (2016-2021e) & (mg)
Table 93. Europe Primary Antibody Sales by Application (2021-2026) & (mg)
Table 94. Asia-Pacific Primary Antibody Sales by Region (2016-2021e) & (mg)
Table 95. Asia-Pacific Primary Antibody Sales by Region (2021-2026) & (mg)
Table 96. Asia-Pacific Primary Antibody Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Primary Antibody Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Primary Antibody Sales by Type (2016-2021e) & (mg)
Table 99. Asia-Pacific Primary Antibody Sales by Type (2021-2026) & (mg)
Table 100. Asia-Pacific Primary Antibody Sales by Application (2016-2021e) & (mg)
Table 101. Asia-Pacific Primary Antibody Sales by Application (2021-2026) & (mg)
Table 102. South America Primary Antibody Sales by Country (2016-2021e) & (mg)
Table 103. South America Primary Antibody Sales by Country (2021-2026) & (mg)
Table 104. South America Primary Antibody Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Primary Antibody Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Primary Antibody Sales by Type (2016-2021e) & (mg)
Table 107. South America Primary Antibody Sales by Type (2021-2026) & (mg)
Table 108. South America Primary Antibody Sales by Application (2016-2021e) & (mg)
Table 109. South America Primary Antibody Sales by Application (2021-2026) & (mg)
Table 110. Middle East & Africa Primary Antibody Sales by Country (2016-2021e) & (mg)
Table 111. Middle East & Africa Primary Antibody Sales by Country (2021-2026) & (mg)
Table 112. Middle East & Africa Primary Antibody Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Primary Antibody Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Primary Antibody Sales by Type (2016-2021e) & (mg)
Table 115. Middle East & Africa Primary Antibody Sales by Type (2021-2026) & (mg)
Table 116. Middle East & Africa Primary Antibody Sales by Application (2016-2021e) & (mg)
Table 117. Middle East & Africa Primary Antibody Sales by Application (2021-2026) & (mg)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Primary Antibody Typical Distributors
Table 121. Primary Antibody Typical Customers
List of Figures
Figure 1. Primary Antibody Picture
Figure 2. Global Primary Antibody Sales Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Polyclonal Antibody
Figure 5. Global Primary Antibody Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Life Sciences
Figure 8. Laboratory
Figure 9. Global Primary Antibody Market Size, (USD Million) & (mg): 2020 VS 2021 VS 2026
Figure 10. Global Primary Antibody Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Primary Antibody Sales (2016-2026) & (mg)
Figure 12. Global Primary Antibody Price by Type (2016-2026) & (USD/mg)
Figure 13. Global Primary Antibody Production Capacity (2016-2026) & (mg)
Figure 14. Global Primary Antibody Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Primary Antibody Market Drivers
Figure 16. Primary Antibody Market Restraints
Figure 17. Primary Antibody Market Trends
Figure 18. Global Primary Antibody Sales Market Share by Manufacturer in 2020
Figure 19. Global Primary Antibody Revenue Market Share by Manufacturer in 2020
Figure 20. Primary Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Primary Antibody Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Primary Antibody Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Primary Antibody Sales Market Share by Region (2016-2026)
Figure 24. Global Primary Antibody Revenue Market Share by Region (2016-2026)
Figure 25. North America Primary Antibody Revenue (2016-2026) & (USD Million)
Figure 26. Europe Primary Antibody Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Primary Antibody Revenue (2016-2026) & (USD Million)
Figure 28. South America Primary Antibody Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Primary Antibody Revenue (2016-2026) & (USD Million)
Figure 30. Global Primary Antibody Sales Market Share by Type (2016-2026)
Figure 31. Global Primary Antibody Revenue Market Share by Type (2016-2026)
Figure 32. Global Primary Antibody Price by Type (2016-2026) & (USD/mg)
Figure 33. Global Primary Antibody Sales Market Share by Application (2016-2026)
Figure 34. Global Primary Antibody Revenue Market Share by Application (2016-2026)
Figure 35. Global Primary Antibody Price by Application (2016-2026) & (USD/mg)
Figure 36. North America Primary Antibody Sales Market Share by Type (2016-2026)
Figure 37. North America Primary Antibody Sales Market Share by Application (2016-2026)
Figure 38. North America Primary Antibody Sales Market Share by Country (2016-2026)
Figure 39. North America Primary Antibody Revenue Market Share by Country (2016-2026)
Figure 40. United States Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Primary Antibody Sales Market Share by Type (2016-2026)
Figure 44. Europe Primary Antibody Sales Market Share by Application (2016-2026)
Figure 45. Europe Primary Antibody Sales Market Share by Country (2016-2026)
Figure 46. Europe Primary Antibody Revenue Market Share by Country (2016-2026)
Figure 47. Germany Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Primary Antibody Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Primary Antibody Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Primary Antibody Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Primary Antibody Revenue Market Share by Region (2016-2026)
Figure 56. China Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Primary Antibody Sales Market Share by Type (2016-2026)
Figure 63. South America Primary Antibody Sales Market Share by Application (2016-2026)
Figure 64. South America Primary Antibody Sales Market Share by Country (2016-2026)
Figure 65. South America Primary Antibody Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Primary Antibody Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Primary Antibody Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Primary Antibody Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Primary Antibody Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Primary Antibody Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の多発性骨髄腫用モノクローナル抗体市場 2021：企業別、地域別、種類・用途別 The Monoclonal Antibody for Multiple Myeloma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- ポリクローナル抗体市場：世界及び中国市場分析・予測（～2024年） Polyclonal Antibody Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Polyclonal Antibody industry with a focus on the Chinese market. The report provides key statistics on the market status of the Polyclonal Antibody manufactur…
- 世界のCGAT2抗体市場 2021：企業別、地域別、種類・用途別 The CGAT2 Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の抗核抗体（ANA）検査市場 2021：企業別、地域別、種類・用途別 The Anti-nuclear Antibody (ANA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の抗体薬物複合体市場 2021：企業別、地域別、種類・用途別 The Antibody-drug Conjugates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…